Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Extended-Release Tablets and Zofran Oral, Oromucosal
Determining the interaction of Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Extended-Release Tablets and Zofran Oral, Oromucosal and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dasabuvir / ombitasvir / paritaprevir / ritonavir
Brand name: Viekira XR, Viekira Pak
Synonyms: Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir
Generic Name: ondansetron
Brand name: Zofran, Zofran ODT, Zuplenz
Synonyms: Zofran
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Extended-Release Tablets-Zohydro ER
- Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Extended-Release Tablets-Zohydro ER Capsules
- Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Extended-Release Tablets-Zoladex
- Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Extended-Release Tablets-Zoladex (Goserelin Implant 10.8 mg)
- Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Extended-Release Tablets-Zoladex (Goserelin Implant 3.6 mg)
- Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Extended-Release Tablets-Zoladex 3-Month
- Zofran Oral, Oromucosal-Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets
- Zofran Oral, Oromucosal-Omeclamox-Pak
- Zofran Oral, Oromucosal-Omega-3 Fatty Acid Capsules
- Zofran Oral, Oromucosal-Omega-3 Fatty Acids
- Zofran Oral, Oromucosal-Omega-3 polyunsaturated fatty acids
- Zofran Oral, Oromucosal-Omega-3-acid ethyl esters